|
|
Article: U.S. Patent Disclosures.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Alfacell Corp., of Bloomfield, N.J., was awarded U.S. Patent No. 6,423,515 B1, titled "Methods of Making Nucleic Acids Encoding Ribonucleases." The patent protects the methodology for synthesizing gene sequences of ranpirnase (the active component of Onconase) and the genetically engineered variant of ranpirnase.
GlycoDesign Inc., of Toronto, received notices of allowance for patent applications covering ATH, a superactive form of heparin that is covalently linked to antithrombin.
Epimmune Inc., of San Diego, was issued U.S. Patent No. 6,413,935 that includes claims covering the induction of immune responses using the company's Padre technology combined ...